2026-10-25
Materion clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 29,813 +0.55%
S&P 7,744 +0.28%
GOLD $4,039 −0.32%
BTC $80,017 −1.54%
VIX 17.11 +1.18%
latest tape · as of 12:02 UTC
The Screen · Basic Materials · Other Industrial Metals & Mining
Materion Corporation
MTRN · the NYSE · USD · Market cap $5.0B · 3,000 employees
Materion Corporation, together with its subsidiaries, produces advanced engineered materials in the United States, Asia, Europe, and internationally.
Not yet scored221.06 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 12:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price221.06 USD at the 23 Oct 2026 close
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 3.50)
- Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 221.06 against the desk's fair-value range, base estimate 188.63, over the last year.
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 3.50, read 2026-10-28
- Ethical screen not yet scored
Price221.06 USD
Fair value188.63
Ethical score70.0/100
Our investment reviews on this name
2026-10-21Read Distribution239.72-7.8% to today ✓Markup gives way to Distribution after a 16% slide in 10 days
2026-10-11Read Markup285.14-22.5% to today Accumulation gives way to Markup first Markup read since August
2026-10-02Read Accumulation285.14-22.5% to today Distribution gives way to Accumulation after a 23% rise in 4 weeks
2026-09-06Read Distribution232.50-4.9% to today ✓Markup gives way to Distribution after a 6% slide in 9 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
Materion Corporation holds its Distribution at $221.06. The statistical read favours the buyers, held for 2 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 2 days |
| Price at the screen | $221.06 |
| Valuation | 55.88 trailing · 28.43 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.05 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 29.55% | Below 33% | Interest-bearing debt is just 29.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 13.12% | Below 49% | Money owed to the company is 13.1% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Materion clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Materion clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 30%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 14.7% above the base estimate.
Third-party analyst targets: 5 covering, consensus None. The average target sits +38% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsEngineered materials look pricey when cycles turn
Every time a plane gets built or a chip line ramps, someone needs specialty alloys and beryllium parts. Materion supplies them, yet the shares trade at 32 times forward earnings while our fair value sits 41 percent lower. Revenue has jumped 31 percent, but margins remain stuck at 4 percent and return on equity at just 8 percent, numbers that rarely survive a downturn in metals demand.
This is a classic cyclical setup dressed up as growth. The low profit margins and modest returns already signal limited pricing power, and paying a premium multiple simply amplifies the risk that peak-cycle earnings will not last. Three analysts may still say buy, yet the gap to their own median target of 225 dollars shows the market is already stretching.
Ethical screens clear the company, yet valuation and industry cyclicality do not. Peak earnings at elevated multiples have trapped investors before; nothing here suggests this time is different. Analysis, not advice.
| Forward P/E | 28.4xcheap for a company growing this fast |
| Trailing P/E | 55.9xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 4.29 |
| EPS, forward | 8.43 |
| Revenue growth | +42.2%growing very fast |
| Profit margin | 4.3%barely profitable |
| Return on equity | 9.5%a modest return on shareholder capital |
| FCF yield | 0.27% |
| Dividend yield | 23.00% |
| Debt to equity | 0.51moderate, manageable leverage |
| Current ratio | 2.94comfortably covers its short-term bills |
| Beta | 1.05moves a little more than the market |
| Short interest, float | 0.04% |
| 52-week range | 109.61 - 324.99 |
| Market cap | $5.0B |
| Employees | 3,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMTRN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-29
Distribution $221.06
-7.8% Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Distribution $239.72
+0.0% Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21
Distribution · changed $239.72
-4.9% Entry 9
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18
Markup $252.16
-11.6% Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 11.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-10-11
Markup · changed $285.14
+0.0% Entry 7
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-10-02
Accumulation · changed $285.14
+22.6% Entry 6
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 22.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-09-06
Distribution · changed $232.50
+10.3% Entry 5
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 10.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-08-06
Markup $210.84
-14.7% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 14.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-07-18
Markup $247.26
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 58% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 175%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it buy, with a mean price target of $211.
2026-07-03
Markup $247.26
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Materion (MTRN) Stock May Be 40% Undervalued On Future Cash Flow Yahoo Finance · 5d ago
- Materion Corporation to Announce Third Quarter 2026 Financial Results on November 4 Yahoo Finance · 8d ago
- Tungsten Has Tripled in 2026 as U.S. Explorers Race to Drill Yahoo Finance · 28d ago
- Are Basic Materials Stocks Lagging Methanex (MEOH) This Year? Yahoo Finance · 29 Sep 2026
- Long Qualification Cycles and Specialized Products Build Materion’s (MTRN) Competitive Moat Yahoo Finance · 28 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
SKESkeena Resources Limited
USARUSA Rare Earth, Inc.
MPMP Materials Corp
LYSDYLynas Rare Earths Limited
LYSCFLynas Rare Earths Limited
ALMAlmonty Industries Inc.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $202.90 | +11.0% | $0.15 | $1,111 | +11.1% |
| 2 months | $163.23 | +38.0% | $0.15 | $1,381 | +38.1% |
| 3 months | $138.31 | +62.9% | $0.15 | $1,630 | +63.0% |
| 6 months | $130.41 | +72.8% | $0.29 | $1,730 | +73.0% |
| 1 year | $81.94 | +175.0% | $0.57 | $2,756 | +175.6% |
| 2 years | $108.24 | +108.1% | $1.11 | $2,092 | +109.2% |
| 3 years | $107.14 | +110.3% | $1.64 | $2,118 | +111.8% |
| 5 years | $76.04 | +196.3% | $2.63 | $2,998 | +199.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MTRN does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.